Trying a new communication channel can leave you feeling uncertain. However, when it comes to utilizing SMS/text messages to more effectively communicate with your study participants in order to remotely monitor your patients, you don’t have any reason to be scared.

There are usually three (3) reasons we repeatedly hear regarding why clients are hesitant to engage with patients via text messages—and why you should reconsider them.

  1. Patients don’t want another text.
  2. Legal concerns
  3. Uncertainty of how to execute and capitalize on a new communication method.

Delve Health has heard these concerns and can help you navigate them. This will ensure the incorporation of SMS will be a successful endeavor. Sending text messages in real-time will serve as reminders for clinical trial participants to complete their study’s tasks, like eDiary entries, on-time—leading to increased patient compliance overall.

We will concede that maybe not every patient is going to opt-in to your SMS list for the clinical study, however a majority most likely will agree to participate—especially Gen Z, Millennials, and “Xennials” who are used to predominately communicating via their smartphones anyway.

SMS communications does come with its own set of rules and regulations that you do need to abide by. However, if you’re collecting consent properly and using Delve Health’s Clinical StudyPal, you can be rest assured our platform already follows federal and local laws, as well as guidelines for clinical research studies. Through our app, you will only be contacting study participants to remotely monitor them. Increasing communications is a quick and efficient solution that is extremely cost effective, plus the most important benefit of all—increasing overall patient satisfaction.

Those benefits, along with being able to offer more decentralized clinical trials (DCTs) or hybrid trials, will lead your clinical research endeavors successfully into the future.

And last, but of course not the least, Delve Health is here to help.

For the latest information, follow us:



real-time outcomes

Remote Patient Monitoring in Clinical Trials

In 1958, AT&T came out with the Bell 101 modem—the first commercial modem to transmit data via what would later be known as “the
Screen Shot Clinical researcher

Opinion: We Have Been Gifted a New Outlook on Increasing Patient Diversity, Compliance, and Retention in Clinical Trials

ACRP Clinical Researcher—June 21, 2022 Our own co-founder and CEO of Delve Health, Wessam Sonbol was published in the ACRP Clinical Researcher magazine. The
Patient Reported Outcomes

Conversations On the Ground—Traditional CROs vs. Virtual CROs

Delve Health’s upper management is currently attending the Drug Information Association’s (DIA) 2022 Global Annual Meeting in Chicago, Illinois. While we are taking all
Screen Shot afortiori development

Delve Health and Afortiori Development Announced Their Collaboration. What Does it Mean for Clinical Research?

Delve Health, a clinical research technology firm, and Afortiori Development, a clinical contract research organization (CRO), have announced an exciting partnership to expand patient
clinical trail day screenshot

Clinical Trials Day

May 20, 2022—Today is Clinical Trials Day. A day to recognize and raise awareness as to why clinical trials are so important to all
Patient Recruitment

Is Your Site Struggling to Recruit Patients for Upcoming Clinical Trials?

Almost 70% of eligible patients live more than two hours away from sites. This geographical challenge has led sponsors to seek out ways to